Comparing Cross-Linked and Non-Cross-Linked Hyaluronic Acid for Early Healing After Tooth Extraction
Effect of Cross-Linked vs Non-Cross-Linked Hyaluronic Acid on Early Soft Tissue Healing After Tooth Extraction: A Randomized Blinded Clinical Trial
This study compares early healing after a non-surgical tooth extraction in adults. Participants are assigned by chance to one of three groups: cross-linked hyaluronic acid placed in the extraction site using a gelatin sponge; non-cross-linked hyaluronic acid placed using a gelatin sponge; or a gelatin sponge alone. The study team measures the wound area using photographs at the time of extraction and on days 3, 7, and 14. A clinician who does not know the assigned group also assesses healing. Participants report their pain and use of pain-relief medicine. The study compares healing among the three groups.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mórfou, Cyprus, 99750
- Cyprus Health and Social Sciences University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18-45 years
- Systemically healthy
- Light smokers, instructed to abstain completely from smoking for the first 72 postoperative hours
- Requiring simple posterior tooth extraction
- Clinically achievable hemostasis
Exclusion Criteria:
- Systemic diseases affecting healing
- Pregnancy or lactation
- Acute infection at the extraction site
- Use of anti-inflammatory or immunosuppressive drugs
- Surgical extraction requiring flap elevation or bone removal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Cross-Linked HA + Gelatin Sponge
Participants receive cross-linked hyaluronic acid delivered via a gelatin sponge after non-surgical tooth extraction. |
Cross-linked sodium hyaluronate 1% applied locally to the extraction socket using a gelatin sponge after non-surgical tooth extraction. Gelatin sponge placed in the extraction socket without hyaluronic acid after non-surgical tooth extraction. |
|
Experimental: Non-Cross-Linked HA + Gelatin Sponge
Participants receive non-cross-linked hyaluronic acid delivered via a gelatin sponge after non-surgical tooth extraction. |
Gelatin sponge placed in the extraction socket without hyaluronic acid after non-surgical tooth extraction. Non-cross-linked low-molecular-weight hyaluronic acid applied locally to the extraction socket using a gelatin sponge after non-surgical tooth extraction. |
|
Active Comparator: Gelatin Sponge Alone
Participants receive a gelatin sponge alone after non-surgical tooth extraction. |
Gelatin sponge placed in the extraction socket without hyaluronic acid after non-surgical tooth extraction. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ercentage Reduction in Wound Area
Time Frame: Postoperative days 0, 3, 7, and 14
|
Wound area will be measured from standardized, calibrated clinical photographs using ImageJ. Percentage reduction will be calculated relative to baseline: [(baseline wound area - follow-up wound area) / baseline wound area] × 100. Results will be compared among the three groups over time. |
Postoperative days 0, 3, 7, and 14
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound Healing Score (WHS)
Time Frame: Postoperative days 3, 7, and 14
|
Clinical wound healing will be assessed using the study's WHS, with a total score ranging from 0 to 9. |
Postoperative days 3, 7, and 14
|
|
Index of Postoperative Recovery (IPR)
Time Frame: Postoperative days 3, 7, and 14
|
Postoperative recovery will be assessed using the IPR measure specified in the study protocol. |
Postoperative days 3, 7, and 14
|
|
Postoperative Pain Intensity
Time Frame: Postoperative days 1, 3, and 7
|
Pain intensity will be recorded using a 10-cm visual analogue scale (VAS), where 0 indicates no pain and 10 indicates the worst pain. |
Postoperative days 1, 3, and 7
|
|
Postoperative Analgesic Consumption
Time Frame: Postoperative days 1-7
|
The number of analgesic doses taken by each participant will be recorded in the postoperative medication log. |
Postoperative days 1-7
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- KSTU//2026/026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.